Tumor Ablation Therapy Devices Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.64 billion in 2023 to $0.74 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to cancer incidence, technological advancements, aging population, minimally invasive procedures.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.27 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, ai and image-guided ablation, telemedicine and remote consultations, training and education. Major trends in the forecast period include advancements in ablation technologies, imaging guidance, robotic and navigation assistance, immuno-oncology integration, percutaneous and image-guided ablation.

Market Overview -
Tumor ablation therapy devices are minimally invasive devices used in the treatment of tumors, commonly of kidney, liver and lung.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp

Increasing Prevalence Of Cancer Drives Tumor Ablation Therapy Device Market Growth
The increasing prevalence of cancer is a key factor driving the growth of the tumor ablation therapy devices market. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide. Tumor ablation is a minimally invasive procedure widely used in the treatment of lung, liver, kidney, and bone tumors. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1,958,310 new cancer cases are expected to be diagnosed in the US, an increase compared to more than 1,918,030 new cancer cases in 2022. The procedure is an effective method for patients who have failed chemotherapy or radiotherapy, thereby supporting the tumor ablation therapy devices market growth.

Competitive Landscape -
Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew plc, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

Innovations In Tumor Ablation Therapy Devices By Leading Companies
Major companies operating in the tumor ablation therapy devices are focusing on technology advancements for shorter procedures, increased safety, lower exposure to radiation, faster learning curves, and improved outcomes J&J medicals have released a microwave ablation system called NEUWAVE, which is the first minimally invasive device to put electrodes into cancer cells and thereby increase the temperature around them for burning the cancer cells. For instance, in April 2023, Compal Electronics, a Taiwan-based electronics manufacturing company, launched AblatePal, a new radiofrequency ablation (RFA) system designed for the percutaneous, intraoperative coagulation and ablation of soft tissue, encompassing the partial or complete treatment of non-resectable liver lesions. It operates by harnessing the heat energy produced through electrical resistance as the current passes through the tissue, ultimately leading to the eradication of the specific targeted tissue. This system finds application in therapeutic medical devices and has been engineered to address a wide range of medical conditions, notably including cancer.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Key Segments -
The tumor ablation therapy devices market covered in this report is segmented -
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.